173 related articles for article (PubMed ID: 23576104)
1. Characterization of TRIP6-dependent nasopharyngeal cancer cell migration.
Fei J; Li J; Shen S; Zhou W
Tumour Biol; 2013 Aug; 34(4):2329-35. PubMed ID: 23576104
[TBL] [Abstract][Full Text] [Related]
2. TRIP6 regulates p27 KIP1 to promote tumorigenesis.
Lin VT; Lin VY; Lai YJ; Chen CS; Liu K; Lin WC; Lin FT
Mol Cell Biol; 2013 Apr; 33(7):1394-409. PubMed ID: 23339869
[TBL] [Abstract][Full Text] [Related]
3. Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.
Wang Y; Dong L; Liu Y
Cancer Biother Radiopharm; 2019 Oct; 34(8):529-536. PubMed ID: 31424277
[No Abstract] [Full Text] [Related]
4. TRIP6 accelerates the proliferation and invasion of cervical cancer by upregulating oncogenic YAP signaling.
Yang F; Li L; Zhang J; Zhang J; Yang L
Exp Cell Res; 2020 Nov; 396(1):112248. PubMed ID: 32853630
[TBL] [Abstract][Full Text] [Related]
5. TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity.
Lin VT; Lin FT
Cell Signal; 2011 Nov; 23(11):1691-7. PubMed ID: 21689746
[TBL] [Abstract][Full Text] [Related]
6. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
[TBL] [Abstract][Full Text] [Related]
7. The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration.
Lai YJ; Lin VT; Zheng Y; Benveniste EN; Lin FT
Mol Cell Biol; 2010 Dec; 30(23):5582-96. PubMed ID: 20876301
[TBL] [Abstract][Full Text] [Related]
8. TRIP6 promotes tumorigenic capability through regulating FOXC1 in hepatocellular carcinoma.
Wang F; Zhang B; Xu X; Zhu L; Zhu X
Pathol Res Pract; 2020 Apr; 216(4):152850. PubMed ID: 32046874
[TBL] [Abstract][Full Text] [Related]
9. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.
Xu J; Lai YJ; Lin WC; Lin FT
J Biol Chem; 2004 Mar; 279(11):10459-68. PubMed ID: 14688263
[TBL] [Abstract][Full Text] [Related]
10. The Zyxin-related protein thyroid receptor interacting protein 6 (TRIP6) is overexpressed in Ewing's sarcoma and promotes migration, invasion and cell growth.
Grunewald TG; Willier S; Janik D; Unland R; Reiss C; Prazeres da Costa O; Buch T; Dirksen U; Richter GH; Neff F; Burdach S; Butt E
Biol Cell; 2013 Nov; 105(11):535-47. PubMed ID: 24033704
[TBL] [Abstract][Full Text] [Related]
11. LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.
Gao Q; Tang L; Wu L; Li K; Wang H; Li W; Wu J; Li M; Wang S; Zhao L
Cell Death Dis; 2018 Mar; 9(3):393. PubMed ID: 29531214
[TBL] [Abstract][Full Text] [Related]
12. TRIP6, as a target of miR-7, regulates the proliferation and metastasis of colorectal cancer cells.
Ling Y; Cao C; Li S; Qiu M; Shen G; Chen Z; Yao F; Chen W
Biochem Biophys Res Commun; 2019 Jun; 514(1):231-238. PubMed ID: 31029422
[TBL] [Abstract][Full Text] [Related]
13. Defining the role of TRIP6 in cell physiology and cancer.
Willier S; Butt E; Richter GH; Burdach S; Grunewald TG
Biol Cell; 2011 Dec; 103(12):573-91. PubMed ID: 22054418
[TBL] [Abstract][Full Text] [Related]
14. c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation.
McMichael BK; Meyer SM; Lee BS
J Biol Chem; 2010 Aug; 285(34):26641-51. PubMed ID: 20547766
[TBL] [Abstract][Full Text] [Related]
15. PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.
Lai YJ; Lin WC; Lin FT
J Biol Chem; 2007 Aug; 282(33):24381-7. PubMed ID: 17591779
[TBL] [Abstract][Full Text] [Related]
16. [Down-regulation of TRIP6 expression induces actin cytoskeleton rearrangements in human carcinoma cell lines].
Gur'ianova OA; Sablina AA; Chumakov PM; Frolova EI
Mol Biol (Mosk); 2005; 39(5):905-9. PubMed ID: 16240724
[TBL] [Abstract][Full Text] [Related]
17. Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression.
Lee BS; Kang S; Kim KA; Song YJ; Cheong KH; Cha HY; Kim CH
Cell Death Dis; 2014 Apr; 5(4):e1159. PubMed ID: 24722284
[TBL] [Abstract][Full Text] [Related]
18. TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule, promotes invasiveness.
Chastre E; Abdessamad M; Kruglov A; Bruyneel E; Bracke M; Di Gioia Y; Beckerle MC; van Roy F; Kotelevets L
FASEB J; 2009 Mar; 23(3):916-28. PubMed ID: 19017743
[TBL] [Abstract][Full Text] [Related]
19. c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration.
Lai YJ; Chen CS; Lin WC; Lin FT
Mol Cell Biol; 2005 Jul; 25(14):5859-68. PubMed ID: 15988003
[TBL] [Abstract][Full Text] [Related]
20. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
